ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter: payments to doctors
Payments that named ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $2.8M
- Providers
- 4,193
- Transactions
- 10,610
- Average per transaction
- $265
The per-transaction average — $265 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4,193 providers the average total is $669, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Silk Road Medical, Inc. | $2,794,532 | 99.6% |
| Boston Scientific | $11,824 | 0.4% |